Structural Basis for Molecular Recognition at Serotonin Receptors

Chong Wang(Scripps Research Institute), Yi Jiang(Scripps Research Institute), Jinming Ma(Scripps Research Institute), Huixian Wu(Scripps Research Institute), Daniel Wacker(Scripps Research Institute), Vsevolod Katritch(Scripps Research Institute), Gye Won Han(Scripps Research Institute), Wei Liu(Scripps Research Institute), Xi‐Ping Huang(University of North Carolina at Chapel Hill), Eyal Vardy(University of North Carolina at Chapel Hill), John D. McCorvy(University of North Carolina at Chapel Hill), Xiang Gao(Van Andel Institute), X. Edward Zhou(Van Andel Institute), Karsten Melcher(Van Andel Institute), Chenghai Zhang(Van Andel Institute), Fang Bai(Dalian University of Technology), Huaiyu Yang(Chinese Academy of Sciences), Linlin Yang(Chinese Academy of Sciences), Hualiang Jiang(Chinese Academy of Sciences), Bryan L. Roth(University of North Carolina at Chapel Hill), Vadim Cherezov(Scripps Research Institute), Raymond C. Stevens(Scripps Research Institute), H. Eric Xu(Van Andel Institute)
Science
March 22, 2013
Cited by 521Open Access
Full Text

Abstract

Serotonin or 5-hydroxytryptamine (5-HT) regulates a wide spectrum of human physiology through the 5-HT receptor family. We report the crystal structures of the human 5-HT1B G protein-coupled receptor bound to the agonist antimigraine medications ergotamine and dihydroergotamine. The structures reveal similar binding modes for these ligands, which occupy the orthosteric pocket and an extended binding pocket close to the extracellular loops. The orthosteric pocket is formed by residues conserved in the 5-HT receptor family, clarifying the family-wide agonist activity of 5-HT. Compared with the structure of the 5-HT2B receptor, the 5-HT1B receptor displays a 3 angstrom outward shift at the extracellular end of helix V, resulting in a more open extended pocket that explains subtype selectivity. Together with docking and mutagenesis studies, these structures provide a comprehensive structural basis for understanding receptor-ligand interactions and designing subtype-selective serotonergic drugs.


Related Papers

No related papers found

Powered by citation graph analysis